Elisabeth B. Wilson, MD, joins D-HH and Dartmouth’s Geisel School of Medicine as new chair of the Department of Community and Family Medicine
Dr. Wilson has accepted the role as chair and professor of the Department of Community and Family Medicine for the D-HH system and Dartmouth’s Geisel School of Medicine. She begins her role in March 2022 and will succeed Cathleen Morrow, MD as chair.
Mt. Ascutney Hospital and Health Center (MAHHC) has announced that Hannah Bianchi has been named as the new Chief Operating Officer (COO) of the Hospital.
2021 Flu Clinic Schedule Announced by Mt. Ascutney Hospital and Health Center and Ottauquechee Health Center
The flu season will soon be here, so Mt. Ascutney Hospital and Health Center (MAHHC) in Windsor, Vermont and Ottauquechee Health Center in Woodstock, Vermont will offer flu vaccinations clinics this fall.
D-HH has named Daisy Goodman, DNP, MPH, CARN-AP, APRN, CNM, as the vice chair of Research for Obstetrics and Gynecology (OB/GYN).
Nicholas Doiron, Nutrition Services is named July’s Employee of the Month by Mt. Ascutney Hospital and Health Center
Mt. Ascutney Hospital and Health Center (MAHHC) has announced that Nicholas Doiron, a Dietary Aide with the Nutrition Services staff at the Hospital, has been chosen as Employee of the Month for July, 2021.
Responding to labor shortage, health system makes second major minimum wage adjustment in nine months
D-HH Launches Third Installment of its Virtual Roundtable Series as Effects of COVID-19 Pandemic Continue
“Heads Up: Coping Through COVID-19” is a pre-recorded series of virtual conversations featuring D-HH mental health experts, community partners and other experts offering information and tips for people of all ages
National staffing crisis, pandemic resurgence have increased local impacts; health providers ask for understanding and patience as they make the best, difficult decisions to ensure excellent care
Mt. Ascutney Hospital and Health Center (MAHHC) announced today that it has earned the Go Clear Award for its achievement in eliminating hazardous smoke from its surgical procedures.
The U.S. Food and Drug Administration (FDA) authorized the use of a third dose of the Pfizer and Moderna COVID-19 vaccines for immunocompromised people, with the third dose to be administered at least 28 days following the first two doses.